Fiche publication


Date publication

février 2022

Journal

Gynecologic oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GRAESSLIN Olivier


Tous les auteurs :
Parpex G, Bucau M, Estevez JP, Raimond E, Ouldamer L, Carcopino X, Touboul C, Bendifallah S, Graesslin O, Lavoue V, Bolze PA, Koskas M,

Résumé

Vulvar carcinoma is a rare disease accounting for 3%-5% of all gynaecological cancers. Although surgery is the standard treatment at an early stage, the outcomes are highly correlated with clear resection margins. Therefore, surgical defects can be important and require reconstruction. The aim of this study was to evaluate vulvar reconstructions using a previously validated nomogram predicting the risk of local recurrence at 2 years.

Mots clés

Oncologic surgery, Vulvar cancer, Vulvar reconstruction

Référence

Gynecol Oncol. 2022 Feb 14;: